Given this data, the investigators believe that the SCC tumor cells may favorably suppress immune activity in local blood endothelial cells by upregulating CD200 expression in these endothelial cells, facilitating the tumor’s entry into the circulatory system and, therefore, metastasis (61). Here, CD200 is linked to neoplasm.